Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
Background: Dementia is a major public health concern affecting approximately 47 million people worldwide. Mild cognitive impairment (MCI) is one form of dementia that affects an individual’s memory with or without affecting their daily life. Alzheimer’s disease dementia (ADD) is...
Main Authors: | Virginie Bottero, Judith A. Potashkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/21/5403 |
Similar Items
-
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
by: Georg Adler, et al.
Published: (2018-02-01) -
Judgment in Mild Cognitive Impairment and Alzheimer's disease
by: Patrícia Helena Figueirêdo Vale Capucho, et al. -
Mild cognitive impairment (part 1): clinical characteristics and predictors of dementia
by: Orestes V. Forlenza, et al.
Published: (2013-06-01) -
Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer’s disease
by: Shuxia Qian, et al.
Published: (2021-04-01) -
Reduced Sympathetic Response to Head-Up Tilt in Subjects with Mild Cognitive Impairment or Mild Alzheimer's Dementia
by: Marte Rognstad Mellingsæter, et al.
Published: (2015-03-01)